{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/insulin-therapy-in-type-1-diabetes/how-this-topic-was-developed/declarations-of-interest/","result":{"pageContext":{"chapter":{"id":"6d600b94-edf3-51e4-85d9-72002fbf5fc5","slug":"declarations-of-interest","fullItemName":"Declarations of interest","depth":2,"htmlHeader":"<!-- begin field e46619e0-9a60-424f-bbcd-a7f30017e069 --><h2>Declarations of interest</h2><!-- end field e46619e0-9a60-424f-bbcd-a7f30017e069 -->","summary":null,"htmlStringContent":"<!-- begin item d7895677-3452-4d53-a471-a7f30015bd73 --><!-- begin field 8fcb7113-15d8-4c91-8cb8-a7f30017e069 --><h2>Our policy</h2><!-- end field 8fcb7113-15d8-4c91-8cb8-a7f30017e069 --><!-- begin field 65b5b7d8-d5af-4d5b-b2d4-a7f30017e069 --><p>Clarity Informatics requests that all those involved in the writing and reviewing of topics, and those involved in the external review process to declare any competing interests. Signed copies are securely held by Clarity Informatics and are available on request with the permission of the individual. A copy of the declaration of interest form which participants are asked to complete annually is also available on request. A brief outline of the declarations of interest policy is described here and full details of the policy is available on the <a href=\"https://cks.clarity.co.uk/\" data-hyperlink-id=\"19359e02-3904-4320-ac03-a93100a6a75e\">Clarity Informatics website</a>. Declarations of interests of the authors are not routinely published, however competing interests of all those involved in the topic update or development are listed below. Competing interests include:</p><ul><li>Personal financial interests</li><li>Personal family interest</li><li>Personal non-financial interest</li><li>Non-personal financial gain or benefit</li></ul><p>Although particular attention is given to interests that could result in financial gains or losses for the individual, competing interests may also arise from academic competition or for political, personal, religious, and reputational reasons. An individual is not obliged to seek out knowledge of work done for, or on behalf of, the healthcare industry within the departments for which they are responsible if they would not normally expect to be informed.</p><!-- end field 65b5b7d8-d5af-4d5b-b2d4-a7f30017e069 --><!-- begin field a749dd3b-d495-4b4b-8b04-a7f30017e069 --><h2>Who should declare competing interests?</h2><!-- end field a749dd3b-d495-4b4b-8b04-a7f30017e069 --><!-- begin field 0ba755eb-dddd-4dd1-8cbb-a7f30017e069 --><p>Any individual (or organization) involved in developing, reviewing, or commenting on clinical content, particularly the recommendations should declare competing interests. This includes the authoring team members, expert advisers, external reviewers of draft topics, individuals providing feedback on published topics, and Editorial Steering Group members. Declarations of interest are completed annually for authoring team and editorial steering group members, and are completed at the start of the topic update and development process for external stakeholders.</p><!-- end field 0ba755eb-dddd-4dd1-8cbb-a7f30017e069 --><!-- begin field 0b9519b5-59ca-4450-9c4c-a7f30017e069 --><h2>Competing interests declared for this topic:</h2><!-- end field 0b9519b5-59ca-4450-9c4c-a7f30017e069 --><!-- begin field 0e040a99-c332-49a2-b6b4-a7f30017e069 --><p>None.</p><!-- end field 0e040a99-c332-49a2-b6b4-a7f30017e069 --><!-- end item d7895677-3452-4d53-a471-a7f30015bd73 -->","topic":{"id":"418fc016-0e56-5e3b-b2ea-3927d2911520","topicId":"fea45be3-7039-4e82-a497-8f104e2219fa","topicName":"Insulin therapy in type 1 diabetes","slug":"insulin-therapy-in-type-1-diabetes","lastRevised":"Last revised in JulyÂ 2020","chapters":[{"id":"954264ab-b538-5bf1-97b7-0f924f8d8cf8","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"3ff43781-7d14-5b7f-afad-bdf21a03a066","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"2847fe29-3881-5cdb-a7bc-46613048cf07","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"cca9cb48-98c0-532b-be68-7babcbefb124","slug":"changes","fullItemName":"Changes"},{"id":"d93b8dec-544f-532d-902d-66e613ea505d","slug":"update","fullItemName":"Update"}]},{"id":"ec62a12c-2df5-5ba3-83ae-04575a5df833","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"bea46ae9-5b5d-5501-8642-95bebd864aa1","slug":"goals","fullItemName":"Goals"},{"id":"637cdedd-d944-52d1-9428-f71dedd59179","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"ecc1db03-98d4-5682-a7a3-7d52d3da9b84","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"ef866cac-6d08-5a10-a858-cbbf60d218e6","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"2dc6198c-0433-5023-aa1b-6862a4d3ed59","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"a289174b-e042-5fce-924a-1f34b54849a9","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"bad524b5-e1b5-52b0-aa55-2cc89cb11660","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"457536b7-af83-548a-b54e-8d0edaeafd3f","slug":"what-is-insulin","fullItemName":"What is insulin?"}]},{"id":"e457b08c-e5c6-5790-ba8c-f88e071da0b0","fullItemName":"Management","slug":"management","subChapters":[{"id":"676c7992-874b-537d-8c19-1f2960b3cc32","slug":"insulin-therapy-type-1-diabetes","fullItemName":"Scenario: Insulin therapy - type 1 diabetes"}]},{"id":"4beb3cd5-7f83-5f1c-9623-cc5e61eae703","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"5da0d096-2a12-5776-bc2b-bd37233342e8","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"8863b2a8-ba84-522f-8b51-20da713ec903","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"b16eeb02-30c3-54db-ad00-8543e4b4cef6","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"452ae6ee-2e11-57b1-bbed-4515efd11fc8","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"ead30a9a-3f18-5514-8a77-69d9bf069d3c","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"6d600b94-edf3-51e4-85d9-72002fbf5fc5","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"6648325a-6d11-5ed7-9bb9-aff9e9d4ee55","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"5da0d096-2a12-5776-bc2b-bd37233342e8","slug":"how-this-topic-was-developed","fullItemName":"How this topic was developed"},"subChapters":[]}}},"staticQueryHashes":["3666801979"]}